Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

 Image Added

Kent E. Goklen

(Cornell B.S. '79 ChE)

 
GSK BIOPHARM R&D


Kent Goklen is the Director of Downstream Process Development at GlaxoSmithKline Biopharm R&D in King of Prussia, PA, with responsi- bility for the process development, scale-up and tech transfer of purifi- cation processes for biopharmaceuticals. Kent joined GSK in 2008, after retiring from the Merck Research Laboratories, where he had led a team in the BioProcess R&D organization. While at Merck, he played a key role in the development and demonstration of processes for Mevacor/Zo- corTM ZocorTM and Cancidas.® Kent has a B.S. from Cornell University and M.S. and Ph.D. degrees from MIT, all in Chemical Engineering. Kent is a Fel- low of the American Chemical Society, where he is active in the Division of Biochemical Technology, and is Adjunct Professor of Chemical and Biomolecular Engineering at Cornell University. 


Mailstop UE0550
709 Swedeland Road
PO Box 1539
King of Prussia, PA 19406

610 270-4793

kent.goklen@gsk.com